Singapore Contract Research Outsourcing Market Outlook to 2022 - by Phase I, Phase II, Phase III, Phase IV, Pre-Clinical Market, Data Management, Biostatistics, Central Laboratory Services, Pharmacovigilance, Bioanalytics and HEOR

Singapore Contract Research Outsourcing Market Outlook to 2022 - by Phase I, Phase II, Phase III, Phase IV, Pre-Clinical Market, Data Management, Biostatistics, Central Laboratory Services, Pharmacovigilance, Bioanalytics and HEOR


  • Products Id :- KR667
  • |
  • Pages: 54
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

The report titled "Singapore Contract Research Organization Market Outlook to 2022 - by Phase I, Phase II, Phase III, Phase IV, Pre-Clinical Market, Data Management, Biostatistics, Central Laboratory Services, Pharmacovigilance, Bioanalytics and HEOR" covers aspects such as CRO market segment (by Phase I, Phase II, Phase III, Phase IV, Pre-Clinical Market, Data Management, Biostatistics, Central Laboratory Services, Pharmacovigilance, Bioanalytics and HEOR), by Number of Clinical Trials, by Therapeutic Area (Oncology, Clinical Pharmacology, gastroenterology & hepatology, Dermatology, cardiology, diagnostic imaging, infectious diseases, ophthalmology and others), and covering competitive landscape of major CRO companies including Singapore Clinical Research Institute (SCRI), Phoenix Pharma Central Services (S) Pte Ltd, Maccine Pte Ltd, Covance (Asia) Pte Ltd, Quintiles East Asia Pte Ltd, EPS Global Research Pte Ltd., ICON Clinical Research Pte Ltd, PPD Development (S) Pte Ltd, PAREXEL International Corporation, PRA Singapore, Syneos Health, Novotech, and SGS. The report concludes with market projection for future and analyst recommendations highlighting the major opportunities and cautions.

Singapore CRO Market

Singapore CRO Market
Singapore CRO market has inclined at positive CAGR during 2013-2017. The market is majorly driven by patent expiration of main revenue-generating drugs, competition from the generic versions of branded drugs, and increasing research and development costs which have pushed pharmaceuticals manufacturers to look for strategies to cut costs and speed up the R&D processes. The manufacturers struggle to renew their pipelines while facing the challenges of efficient drug discovery which has propelled growth in the contract research outsourcing industry in Singapore. Further, the market is supported by best in class infrastructure for research, highly skilled workforce, Strong intellectual property (IP) and legal infrastructure and government support.

Singapore CRO Market Segmentation
The CRO market includes revenue generated from Phase I, II, II, IV clinical trials, Pre-clinical market, data management, biostatistics, and central laboratory services, Pharmacovigilance, Bioanalytics and HEOR. Growing emphasis on translational research within pharmaceutical R&D due to the government’s commitment to scientific research has propelled the growth of pre-clinical market in Singapore. Early phase clinical trials such as Phase I and Phase II are rising rapidly owing to its small patient pool, strong legal and political system, world-class infrastructure and connectivity, and access to talents. Other services such as Pharmacovigilance has witnessed increase in revenue as their scope expanded from just addressing ADR (Adverse Drug Reaction) to risk management plans and also because it also complies with local and global regulations. Bioanalytics is growing, as high cost and risk has led pharmaceutical companies to outsource more of pre-clinical and early phase development services.
The oncology segment has accounted for more than half of the clinical trials in 2015. Major factor driving the oncology segment include rising cases of cancer, availability of government funding for research purposes, and growing expertise for cancer by CROs. Other major therapeutic segments include clinical pharmacology, gastroenterology & hepatology, cardiology, diagnostic imaging, infectious diseases, ophthalmology and others.

Singapore CRO Market Competition Overview

CRO market in Singapore is dominated by MNCs that are capitalizing on the increasing government support for clinical research and foreign investment. The number of clinical trials increased due to establishment of more clinical trial units and more patient participation that gives them the opportunity to access innovative experimental treatments that are not yet available in the market. The market is concentrated with top 10 companies occupying more than half of the overall market revenue. Major competition parameters include service portfolio and therapeutic areas covered by the Contract Research organization

Singapore CRO Market Future Potential
Singapore CRO market is expected to grow at a positive CAGR during 2018-2022. The two most significant market growth drivers are the reduction of drug lag and cost. Other growth drivers such as vendor consolidation and increased outsourcing penetration will further augment the CRO market in Singapore.

Key Topics Covered in the Report:

  • Singapore CRO Market Size, 2013-2017
  • Singapore Phase I, Phase II, Phase II, Phase IV, Data Management, Pre-Clinical, Biostatistics, Central Laboratory Services, Pharmacovigilance, Bioanalytics, and HEOR Market Size, 2013-2017
  • Singapore CRO Market Segmentation(by Major Therapeutic Segments and by Phase of Clinical Trial)
  • Trends and Developments in Singapore CRO Market
  • Government Initiatives, Rules and Regulations in Singapore CRO Market
  • Singapore CRO Market Competitive Landscape
  • Singapore CRO Future Outlook and Projections, 2018-2022
  • Value Chain in Singapore CRO Industry


Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1. Research Methodology

1.1. Market Definitions
1.2. Abbreviations
1.3. Consolidated Research Approach
1.4. Variables (Dependent and Independent)
1.5. Singapore Hospital Market Correlation Matrix
1.6. Singapore Hospital Market Regression Matrix

2. Singapore Contract Research Organization Market - Executive Summary

3. Singapore Healthcare Ecosystem

4. Singapore Healthcare System

5. Singapore Healthcare Key Metrics

6. Comparative Analysis with Other Asian Countries

7. Singapore Contract Research Organization Market: Overview and Market Size- 2013-2017

8. Singapore Contract Research Organization Market Segmentation

9. Singapore Contract Research Organization Market - Growth Drivers

10. Singapore Contract Research Organization Market - Government Regulations

10.1. Government Regulations for Clinical Trials of Therapeutic Products
10.2. Government Regulations for Clinical Trials of Medicinal Products

11. Value Chain in Contract Research Organization

11.1. Value Chain in Contract Research Organization: Challenges

12. CRO Market Competitive Landscape

12.1. CRO Market Competition Analysis
12.2. Singapore Clinical Research Institute (SCRI)
12.3. Competition Matrix for Major Players in Singapore CRO Market

13. Singapore CRO Market Future Outlook and Projections, 2018-2022

14. Disclaimer

Figure 2-1: Singapore Contract Research Organization Market Size by Revenue in USD Million, 2013, 2015 and 2017
Figure 2-2: Singapore Contract Research Organization Market Segmentation by Therapeutic Area, 2015
Figure 2-3: Singapore Contract Research Organization Market Segmentation by Phase on the Basis of Number of Clinical Trials, 2015
Figure 2-4: Singapore Contract Research Organization Market Size on the Basis of Number of Clinical Trials, 2011, 2013 and 2015
Figure 4-1: Singapore Healthcare System
Figure 5-1: Top Causes of Death in Singapore, 2016
Figure 7-1: Singapore Contract Research Organization Market Size on the Basis of Revenue in USD Million and Growth Rate in Percentage (%), 2013-2017
Figure 7-2: Singapore Contract Research Organization Market Size on the Basis of Number of Clinical Trials, 2011-2015
Figure 7-3: Singapore CRO Phase I Market Size on the Basis of Revenue in USD Million, 2013-2017
Figure 7-4: Singapore CRO Phase II Market Size on the Basis of Revenue in USD Million, 2013-2017
Figure 7-5: Singapore CRO Phase III Market Size on the Basis of Revenue in USD Million, 2013-2017
Figure 7-6: Singapore CRO Phase IV Market Size on the Basis of Revenue in USD Million, 2013-2017
Figure 7-7: Singapore CRO Pre-Clinical Market Size on the Basis of Revenue in USD Million, 2013-2017
Figure 7-8: Singapore CRO Data Management Market Size on the Basis of Revenue in USD Million, 2013-2017
Figure 7-9: Singapore CRO Biostatistics Market Size on the Basis of Revenue in USD Million, 2013-2017
Figure 7-10: Singapore CRO Central Laboratory Services Market Size on the Basis of Revenue in USD Million, 2013-2017
Figure 7-11: Singapore CRO Pharmacovigilance Market Size on the Basis of Revenue in USD Million, 2013-2017
Figure 7-12: Singapore CRO Bioanalytics Market Size on the Basis of Revenue in USD Million, 2013-2017
Figure 7-13: Singapore CRO HEOR Market Size on the Basis of Revenue in USD Million, 2013-2017
Figure 8-1: Singapore Contract Research Organization Market Segmentation by Therapeutic Area on the Basis of Number of Clinical Trials, 2015
Figure 8-2: Singapore Contract Research Organization Market Segmentation by Phase on the Basis of Number of Clinical Trials, 2015
Figure 10-1: Applicable Regulations for Clinical Trials of Therapeutic Products and Medicinal Products
Figure 10-2: Clinical Trial Authorization-Clinical Trial Notification (CTA-CTN) system
Figure 10-3: Difference Between Clinical Trial Authorization and Clinical Trial Notification System
Figure 11-1: Value Chain Analysis in Singapore CRO Market
Figure 13-1: Singapore CRO Market Future Outlook and Projections on the Basis of Revenue in USD Million, 2018-2022
Figure 13-2: Singapore CRO Phase II Market Size on the Basis of Revenue in USD Million, 2018-2022
Figure 13-3: Singapore CRO Phase I Market Size on the Basis of Revenue in USD Million, 2018-2022
Figure 13-4: Singapore CRO Phase III Market Size on the Basis of Revenue in USD Million, 2018-2022
Figure 13-5: Singapore CRO Phase IV Market Size on the Basis of Revenue in USD Million, 2018-2022
Figure 13-6: Singapore CRO Phase IV Market Size on the Basis of Revenue in USD Million, 2018-2022
Figure 13-7: Singapore CRO Data Management Market Size on the Basis of Revenue in USD Million, 2018-2022
Figure 13-8: Singapore CRO Biostatistics Market Size on the Basis of Revenue in USD Million, 2018-2022
Figure 13-9: Singapore CRO Pharmcovigilance Market Size on the Basis of Revenue in USD Million, 2018-2022
Figure 13-10: Singapore CRO Central Laboratory Services Market Size on the Basis of Revenue in USD Million, 2018-2022
Figure 13-11: Singapore CRO Bioanalytics Market Size on the Basis of Revenue in USD Million, 2018-2022

Table 1-1: Correlation Matrix for Singapore Hospital Market
Table 1-2: Regression Coefficient Output for Singapore Hospital Market
Table 5-1: Singapore Healthcare Market Key Metrics, 2017
Table 5-2: Singapore Healthcare Personnel, 2017
Table 5-3: Incidence/Prevalence of Major Diseases, 2016
Table 5-4: Number of Cases of Major Infectious Diseases in Singapore, 2012-2017
Table 6-1: Comparison of Singapore Healthcare Statistics with Vietnam, Malaysia, Indonesia, South Korea, India, China and Australia, 2016
Table 6-2: Comparison of Singapore Healthcare Statistics with Vietnam, Malaysia, Indonesia, South Korea, India, China and Australia, 2017
Table 11-1: Major Challenges in Singapore CRO Market Value Chain
Table 12-1: Competition Matrix for Major Companies in Singapore CRO Market
Table 12-2: Competitive landscape of Singapore Clinical Research Institute (SCRI) including Overview, Therapeutic Areas, Services, and Clinical Research Networks
Table 12-3: Competitive landscape of Singapore Clinical Research Institute (SCRI) including Recent Developments, Key projects and Future Strategy
Table 12-4: Number of Patients Enrolled in Clinical Trials and All Research Studies by SCRI, 2014-2016
Table 12-5: Key Collaborators and Funding Sources for SCRI in 2016
Table 12-6: Key Statistics for SCRI as of 2016
Table 12-7: Numbers of Ongoing and Completed Studies since 2008 by Therapeutic class
Table 12-8: Competition Matrix for Phoenix Pharma Central Services (S) Pte Ltd, Maccine Pte Ltd, Covance Pte Ltd, Quintiles East Asia Pte Ltd, EPS Global Research Pte Ltd., ICON Clinical Research Pte Ltd, PPD Development (S) Pte Ltd, PAREXEL International Corporation, Syneos Health, Novotech and SGS

Single User License:
Access to the soft copy of the report will be granted to individual user/ Authorized User within the organization The Authorized User may store, display or archive the information but will not be able to print, copy and use any information in the report for circulation or citation purpose. The individual user will treat the information in the report as confidential and will only use this for internal purpose. In no circumstance, the complete / part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view. The report will be MAC address protected and will only be accessible on 1 platform.

Hard Copy License:
The license provides the access to hard copy/ printed copy of the report to the Authorized User only. The report will be delivered to the user on the address provided during making the purchase. The Authorized User may store, display, or archive the information but will not use any information in the report for circulation or citation purpose. The individual user will treat the information in the report as confidential and will only use this for internal purpose. In no circumstance, the complete / part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view. No soft copy access will be provided in this case.

Corporate User License:
Access to the soft copy of the report will be granted to multiple users within the organization. The users are authorized to store, display, duplicate, archive, print and distribute the information within the organization either electronically or in paper. The users are not authorized to use any information in the report for citation and circulation externally. The users will treat the information in the report as confidential and will only use this for internal purpose. In no circumstance, the complete / part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view.

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Singapore Clinical Research Institute (SCRI), Phoenix Pharma Central Services (S) Pte Ltd, Maccine Pte Ltd, Covance (Asia) Pte Ltd, Quintiles East Asia Pte Ltd, EPS Global Research Pte Ltd., ICON Clinical Research Pte Ltd, PPD Development (S) Pte Ltd, PAREXEL International Corporation, PRA Singapore, Syneos Health, Novotech, and SGS

CRO market segment (by Phase I, Phase II, Phase III, Phase IV, Pre-Clinical Market, Data Management, Biostatistics, Central Laboratory Services, Pharmacovigilance, Bioanalytics and HEOR),by Number of Clinical Trials by Therapeutic Area (Oncology, Clinical Pharmacology, gastroenterology & hepatology, Dermatology, cardiology, diagnostic imaging, infectious diseases, ophthalmology and others)

select a license

Single User License
USD 2000 INR 134900
Hard Copy License
USD 3200 INR 215840
Corporate User License
USD 4000 INR 269800

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com